ALZAMEND NEURO, INC. Prepaid Expense and Other Assets
ALZAMEND NEURO, INC. (ALZN) had Prepaid Expense and Other Assets of $663.44 thousand as of 2026-07-31, per its 10-Q filed 2026-09-10.
Financial Statements › Balance Sheet › Assets
us-gaap:PrepaidExpenseAndOtherAssets · last filed 2026-09-10
- 2026-07-31: Prepaid Expense and Other Assets $663.44K.
- 2026-04-30: Prepaid Expense and Other Assets $1.05M.
- 2026-01-31: Prepaid Expense and Other Assets $986.14K.
- 2025-10-31: Prepaid Expense and Other Assets $272.01K.
| Period end | Prepaid Expense and Other Assets | Prepaid Expense and Other Assets as first filed |
|---|---|---|
| 2026-07-31 | $663.44K 10-Q · filed 2026-09-10 | |
| 2026-04-30 | $1.05M 10-Q · filed 2026-09-10 | |
| 2026-01-31 | $986.14K 10-Q · filed 2026-03-11 | |
| 2025-10-31 | $272.01K 10-Q · filed 2025-12-09 | |
| 2025-07-31 | $307.96K 10-Q · filed 2025-09-10 | |
| 2025-04-30 | $228.72K 10-K · filed 2026-07-22 | |
| 2025-01-31 | $589.21K 10-Q · filed 2025-03-10 | |
| 2024-10-31 | $673.67K 10-Q · filed 2024-12-11 | |
| 2024-07-31 | $222.24K 10-Q · filed 2024-09-11 | |
| 2024-04-30 | $79.19K 10-K · filed 2025-07-22 | |
| 2024-01-31 | $310.74K 10-Q · filed 2024-03-25 | |
| 2023-10-31 | $581.80K 10-Q · filed 2023-12-15 | |
| 2023-07-31 | $718.19K 10-Q · filed 2023-09-13 | |
| 2023-04-30 | $447.59K 10-K · filed 2024-07-30 | |
| 2023-01-31 | $546.30K 10-Q · filed 2023-03-15 | |
| 2022-10-31 | $409.57K 10-Q · filed 2022-12-12 | |
| 2022-07-31 | $587.54K 10-Q · filed 2022-09-13 | |
| 2022-04-30 | $349.72K 10-K · filed 2023-07-27 | |
| 2022-01-31 | $638.83K 10-Q · filed 2022-03-15 | |
| 2021-10-31 | $928.20K 10-Q · filed 2021-12-13 | |
| 2021-07-31 | $349.72K 10-Q · filed 2022-09-13 | $1.20M 10-Q · filed 2021-09-13 |
| 2021-04-30 | $983.32K 10-K · filed 2022-07-19 | |
| 2020-04-30 | $1.62M 10-K · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |